Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B S Roden

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
The Laryngoscope|July 18, 2017
Immunologic responses to a novel DNA vaccine targeting human papillomavirus-11 E6E7Julie Ahn, Shiwen Peng, Chien-Fu Hung, et al.
Cancer Research|December 6, 2006
Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus speciesRatish Gambhira, Patti E Gravitt, Ioannis Bossis, et al.
Plos Pathogens|October 27, 2015
Immunologic Control of Mus musculus Papillomavirus Type 1Joshua W Wang, Rosie Jiang, Shiwen Peng, et al.
Journal of Virology|May 14, 2005
Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infectionIoannis Bossis, Richard B S Roden, Ratish Gambhira, et al.
Plos One|February 6, 2013
Optimization of multimeric human papillomavirus L2 vaccinesSubhashini Jagu, Kihyuck Kwak, Balasubramanyam Karanam, et al.
Virology|December 14, 2011
The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic trafficShahan Mamoor, Zeynep Onder, Balasubramanyam Karanam, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2015
Weight change in breast cancer survivors compared to cancer-free women: a prospective study in women at familial risk of breast cancerAmy L Gross, Betty J May, Jennifer E Axilbund, et al.
Plos One|March 29, 2013
Multivalent human papillomavirus l1 DNA vaccination utilizing electroporationKihyuck Kwak, Rosie Jiang, Subhashini Jagu, et al.
Plos One|July 11, 2024
Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancerRavi K Anchoori, Ssu-Hsueh Tseng, Hua-Ling Tsai, et al.
Clinical Proteomics|May 12, 2017
An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumorsQing Kay Li, Punit Shah, Yuan Tian, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
The Laryngoscope|July 18, 2017
Immunologic responses to a novel DNA vaccine targeting human papillomavirus-11 E6E7Julie Ahn, Shiwen Peng, Chien-Fu Hung, et al.
Cancer Research|December 6, 2006
Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus speciesRatish Gambhira, Patti E Gravitt, Ioannis Bossis, et al.
Plos Pathogens|October 27, 2015
Immunologic Control of Mus musculus Papillomavirus Type 1Joshua W Wang, Rosie Jiang, Shiwen Peng, et al.
Journal of Virology|May 14, 2005
Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infectionIoannis Bossis, Richard B S Roden, Ratish Gambhira, et al.
Plos One|February 6, 2013
Optimization of multimeric human papillomavirus L2 vaccinesSubhashini Jagu, Kihyuck Kwak, Balasubramanyam Karanam, et al.
Virology|December 14, 2011
The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic trafficShahan Mamoor, Zeynep Onder, Balasubramanyam Karanam, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2015
Weight change in breast cancer survivors compared to cancer-free women: a prospective study in women at familial risk of breast cancerAmy L Gross, Betty J May, Jennifer E Axilbund, et al.
Plos One|March 29, 2013
Multivalent human papillomavirus l1 DNA vaccination utilizing electroporationKihyuck Kwak, Rosie Jiang, Subhashini Jagu, et al.
Plos One|July 11, 2024
Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancerRavi K Anchoori, Ssu-Hsueh Tseng, Hua-Ling Tsai, et al.
Clinical Proteomics|May 12, 2017
An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumorsQing Kay Li, Punit Shah, Yuan Tian, et al.
Pageof 14